Literature DB >> 28071899

Near-IR-Absorbing Gold Nanoframes with Enhanced Physiological Stability and Improved Biocompatibility for In Vivo Biomedical Applications.

Liying Wang, Yunching Chen, Hsin Yao Lin1, Yung-Te Hou2, Ling-Chu Yang, Aileen Y Sun, Jia-Yu Liu, Chien-Wen Chang, Dehui Wan.   

Abstract

This paper describes the synthesis of near-infrared (NIR)-absorbing gold nanoframes (GNFs) and a systematic study comparing their physiological stability and biocompatibility with those of hollow Au-Ag nanoshells (GNSs), which have been used widely as photothermal agents in biomedical applications because of their localized surface plasmon resonance (LSPR) in the NIR region. The GNFs were synthesized in three steps: galvanic replacement, Au deposition, and Ag dealloying, using silver nanospheres (SNP) as the starting material. The morphology and optical properties of the GNFs were dependent on the thickness of the Au coating layer and the degree of Ag dealloying. The optimal GNF exhibited a robust spherical skeleton composed of a few thick rims, but preserved the distinctive LSPR absorbance in the NIR region-even when the Ag content within the skeleton was only 10 wt %, 4-fold lower than that of the GNSs. These GNFs displayed an attractive photothermal conversion ability and great photothermal stability, and could efficiently kill 4T1 cancer cells through light-induced heating. Moreover, the GNFs preserved their morphology and optical properties after incubation in biological media (e.g., saline, serum), whereas the GNSs were unstable under the same conditions because of rapid dissolution of the considerable silver content with the shell. Furthermore, the GNFs had good biocompatibility with normal cells (e.g., NIH-3T3 and hepatocytes; cell viability for both cells: >90%), whereas the GNSs exhibited significant dose-dependent cytotoxicity (e.g., cell viability for hepatocytes at 1.14 nM: ca. 11%), accompanied by the induction of reactive oxygen species. Finally, the GNFs displayed good biocompatibility and biosafety in an in vivo mouse model; in contrast, the accumulation of GNSs caused liver injury and inflammation. Our results suggest that GNFs have great potential to serve as stable, biocompatible NIR-light absorbers for in vivo applications, including cancer detection and combination therapy.

Entities:  

Keywords:  biocompatibility; gold nanoframes; hollow Au−Ag nanoshells; localized surface plasmon resonance; photothermal agents; physiological stability

Mesh:

Substances:

Year:  2017        PMID: 28071899     DOI: 10.1021/acsami.6b12591

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  5 in total

1.  Water-Soluble Chitosan Conjugated DOTA-Bombesin Peptide Capped Gold Nanoparticles as a Targeted Therapeutic Agent for Prostate Cancer.

Authors:  Theeranan Tangthong; Thananchai Piroonpan; Velaphi C Thipe; Menka Khoobchandani; Kavita Katti; Kattesh V Katti; Wanvimol Pasanphan
Journal:  Nanotechnol Sci Appl       Date:  2021-03-18

Review 2.  Anisotropic Gold Nanoparticles in Biomedical Applications.

Authors:  Claudia Kohout; Cristina Santi; Laura Polito
Journal:  Int J Mol Sci       Date:  2018-10-29       Impact factor: 5.923

3.  Photocatalytic Activity of Polymer Nanoparticles Modulates Intracellular Calcium Dynamics and Reactive Oxygen Species in HEK-293 Cells.

Authors:  Caterina Bossio; Ilaria Abdel Aziz; Gabriele Tullii; Elena Zucchetti; Doriana Debellis; Mattia Zangoli; Francesca Di Maria; Guglielmo Lanzani; Maria Rosa Antognazza
Journal:  Front Bioeng Biotechnol       Date:  2018-08-23

4.  Self-Assembled Polysaccharide-Diphenylalanine/Au Nanospheres for Photothermal Therapy and Photoacoustic Imaging.

Authors:  Kaiwen Shen; Yuting Huang; Qiuju Li; Min Chen; Limin Wu
Journal:  ACS Omega       Date:  2019-10-25

5.  A multifunctional platform with single-NIR-laser-triggered photothermal and NO release for synergistic therapy against multidrug-resistant Gram-negative bacteria and their biofilms.

Authors:  Baohua Zhao; He Wang; Wenjing Dong; Shaowen Cheng; Haisheng Li; Jianglin Tan; Junyi Zhou; Weifeng He; Lanlan Li; Jianxiang Zhang; Gaoxing Luo; Wei Qian
Journal:  J Nanobiotechnology       Date:  2020-04-15       Impact factor: 10.435

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.